Ligand-binding Assays / Immunoassays

360biolabs stands out as a leader in the field of immunoassay development and validation, with extensive expertise across various methodologies to support clinical therapeutic programs. An immunoassay is a bioanalytical technique employed to identify and measure a specific analyte by utilising its binding interactions with antibodies or antigens. The methodologies and platforms utilised for immunoassays can differ considerably based on the analyte, therapeutic approach, and nature of the analytical endpoint.

Decorative image

Expertise With Custom Immunoassay Solutions: 

Custom Assay Solutions


Our expert immunology team can provide custom solutions for immunoassay development and validation.

Immunoassay Experts

We can tech transfer, optimise, verify, qualify, or validate an immunoassay in a diverse range of matrices, including disease state.

Speed: Fast Turn Around

Fast data turnaround time to expedite your dose escalation (SAD/MAD) study.

Therapeutic areas

We have experience across a multitude of indications, including but not limited to cardiovascular, pulmonary, immunology and inflammation, metabolic, neurologic, oncology, genetic, autoimmune, and infectious diseases.

Modalities

Large Molecule

Our experience in the large molecule space includes:

  • ADC
  • Monoclonal antibodies
  • Bi-specific/tri-specific proteins
  • Enzyme replacements
  • Recombinant proteins

Advanced Therapies

Our experience in the advanced therapies space:

  • Cell therapy
  • Gene therapy
  • CAR cell therapy
  • RNA-based therapy
  • Oligonucleotide therapy
  • Stem cell therapy

Vaccines

Our experience in vaccines:

  •  Inactivated vaccines
  • Live-attenuated vaccines
  • Messenger RNA (mRNA) vaccines
  • Subunit, recombinant, polysaccharide, and conjugate vaccines
  • Toxoid vaccines
  • Viral vector vaccines
Scientist measuring read out on MesoScale Discovery platform (MSD)